A Multi-omics Study of Epithelial Ovarian Cancer

Lei Li

Status: Unknown

Conditions: Metabolomics; Epithelial Ovarian Cancer; Tumor Invasiveness; Transcriptomics; Whole Exome Sequencing; Tumorigenesis

Treatments: Combination Product: A multi-omics analysis

Study type: Observational

Funder types: Other

Identifiers

NCT03742856

EOC-OMICS

Details and patient eligibility

About

This study aims to analyze the multi-omics results between epithelial ovarian cancer (EOC) patient with different FIGO stages and pathological subtypes. The multi-omics profiles include whole exome sequencing, analysis of transcriptomics and metabolomics. A comprehensive multi-omics will reveal the invasiveness and tumorigenesis of EOC.

Enrollment: 80 estimated patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed primary epithelial ovarian cancer
• Signed an approved informed consents
• Feasible for biopsy

Exclusion criteria

• Not meeting all of the inclusion criteria